Anosmia Rehabilitation in Patients Post Coronavirus Disease (COVID 19)

Status Withdrawn

Clinical Trial Summary

The study will be a randomized controlled trial, involving patients with hyposmia/anosmia of onset immediately after an upper respiratory viral illness, assigned to three distinct study arms. Nasal irrigations will be prescribed to all three groups (BID). In addition, one arm will receive a paper hand-out about post-viral anosmia with instructions to smell common household items (current care) and act as a control group. The second group will receive an essential oil retraining kit, whereas the third group will receive the same olfactory training kit and a prescription to use budesonide with the nasal irrigations. Olfactory scores will be tested at the enrollment, 3 months and at 6 months.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04374474
Study type	Interventional
Source	Lawson Health Research Institute
Contact
Status	Withdrawn
Phase	Phase 4
Start date	January 10, 2021
Completion date	March 10, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04617444` - The ESTxENDS Trial- Substudy on Effects of Using Electronic Nicotine Delivery Systems (ENDS) on Olfactory Function	N/A
Completed	`NCT02985515` - Steroid Nasal Irrigation for Flavor Evaluation and Detection Study	N/A
Recruiting	`NCT06066307` - Olfactory Performance in Culinary Arts Students	Phase 4
Completed	`NCT05445921` - Stellate Ganglion Block for COVID-19-Induced Olfactory Dysfunction	Phase 1/Phase 2
Recruiting	`NCT05855369` - Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss	Phase 2/Phase 3
Recruiting	`NCT03574701` - Intranasal Retinoic Acid Treatment for Patients With OlfactoryLOSS: A RANDOMIZED CONTROLLED TRIAL	N/A
Enrolling by invitation	`NCT04764981` - Olfactory Training for Olfactory Dysfunction After Coronavirus Disease - 19 (COVID-19)	N/A
Completed	`NCT03990766` - Smell Changes & Efficacy of Nasal Theophylline	Phase 2
Withdrawn	`NCT05542095` - Simvastatin Nasal Rinses for the Treatment of COVID-19 Mediated Dysomsia	Phase 1
Recruiting	`NCT04791436` - Oral and Olfactory Complications of Recovered COVID-19 Patients
Enrolling by invitation	`NCT05038475` - Clinical and Immunological Responses After SARS-CoV-2 Infection Causing COVID-19
Completed	`NCT01332825` - cAMP (Cyclic Adenosine Monophosphate) Levels in the Nose	N/A
Completed	`NCT04789499` - Smell in Covid-19 and Efficacy of Nasal Theophylline	Phase 2
Active, not recruiting	`NCT04761458` - Correlation of Preoperative Global Olfactory Function With Frailty, Perioperative Neurocognitive Disorders and Mortality	N/A
Completed	`NCT04406584` - Intranasal Injection of PRP Versus Saline for Treatment of Olfactory Dysfunction	N/A
Completed	`NCT03611673` - At-Home Olfactory Training	N/A
Completed	`NCT04700891` - Correlation of Preoperative Olfactory Identification Function With Frailty and Postoperative Complications and Mortality	N/A
Recruiting	`NCT04466982` - Assessment of Olfactory Dysfunction in SARS CoV-2 (COVID-19) Infection
Recruiting	`NCT04869436` - Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis	Phase 4
Recruiting	`NCT05448898` - The Efficacy of Traditional Chinese Medicine in Olfactory Dysfunction	N/A